10-102548689-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016169.4(SUFU):​c.318-1281C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 152,174 control chromosomes in the GnomAD database, including 1,247 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1247 hom., cov: 32)

Consequence

SUFU
NM_016169.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.429

Publications

10 publications found
Variant links:
Genes affected
SUFU (HGNC:16466): (SUFU negative regulator of hedgehog signaling) The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SUFU Gene-Disease associations (from GenCC):
  • medulloblastoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet
  • basal cell nevus syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • ocular motor apraxia, Cogan type
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • Joubert syndrome 32
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Joubert syndrome
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • apraxia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • ciliopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.4 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016169.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUFU
NM_016169.4
MANE Select
c.318-1281C>T
intron
N/ANP_057253.2
SUFU
NM_001178133.2
c.318-1281C>T
intron
N/ANP_001171604.1Q9UMX1-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUFU
ENST00000369902.8
TSL:1 MANE Select
c.318-1281C>T
intron
N/AENSP00000358918.4Q9UMX1-1
SUFU
ENST00000423559.2
TSL:1
c.318-1281C>T
intron
N/AENSP00000411597.2Q9UMX1-3
SUFU
ENST00000369899.6
TSL:1
c.318-1281C>T
intron
N/AENSP00000358915.2Q9UMX1-2

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15329
AN:
152054
Hom.:
1243
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0432
Gnomad AMI
AF:
0.124
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.0626
Gnomad EAS
AF:
0.415
Gnomad SAS
AF:
0.221
Gnomad FIN
AF:
0.0713
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0920
Gnomad OTH
AF:
0.122
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.101
AC:
15356
AN:
152174
Hom.:
1247
Cov.:
32
AF XY:
0.106
AC XY:
7854
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0432
AC:
1793
AN:
41524
American (AMR)
AF:
0.178
AC:
2722
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0626
AC:
217
AN:
3466
East Asian (EAS)
AF:
0.415
AC:
2141
AN:
5162
South Asian (SAS)
AF:
0.222
AC:
1072
AN:
4818
European-Finnish (FIN)
AF:
0.0713
AC:
755
AN:
10596
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0920
AC:
6258
AN:
67998
Other (OTH)
AF:
0.126
AC:
266
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
666
1333
1999
2666
3332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0434
Hom.:
45
Bravo
AF:
0.108
Asia WGS
AF:
0.301
AC:
1042
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.4
DANN
Benign
0.37
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10883735; hg19: chr10-104308446; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.